Results 11 to 20 of about 23,073,058 (182)

Correction of iron deficiency anemia in patients with obstetric and gynecological pathology (pharmacoeconomic comparative analysis) [PDF]

РМЖ. Мать и дитя, 2018
Correction of iron deficiency anemia in patients with obstetric and gynecological pathology (pharmacoeconomic comparative analysis) Dobrohotova Yu.E., Markova E. A. Pirogov Russian National Research Medical University, Moscow The authors provide a
Yu.E. Dobrokhotova, Markova E. A.
doaj   +1 more source

Pharmacoeconomic analysis of flexible-dose administration regimen of Xeomine® in patients with focal dystonia [PDF]

Качественная клиническая практика, 2018
Relevance. ‹The most effective treatment for focal dystonia (blepharospasm (BsP) and cervical dystonia (CD)) is use of botulinum toxin, including onabotulinumtoxinА (BoNTA-Ona), incobotulinumtoxin А (BoNTA-Inco), abobotulinumtoxinА (BoNTA-Abo).
A. E. Cheberda, D. Yu. Belousov, S. K. Zyryanov   +2 more
doaj   +2 more sources

Peroral retard iron preparation for iron-deficiency anemia: case study and pharmacoeconomic analysis [PDF]

РМЖ. Мать и дитя, 2020
Peroral retard iron preparation for iron-deficiency anemia: case study and pharmacoeconomic analysis Yu.E. Dobrokhotova, E.A. Markova Pirogov Russian National Research Medical University, Moscow, Russian Federation Iron-deficiency ...
Yu.E. Dobrokhotova, E.A. Markova
doaj   +1 more source

Pharmacoeconomic Evaluation of Homeopathy: Assessing Efficacy, Economics, and Policy Perspectives [PDF]

Journal of Pharmacoeconomics and Pharmaceutical Management
Background: This narrative review aims to explore the necessity for pharmacoeconomic studies in homeopathy, elucidating key factors and methodologies essential for conducting such assessments.
Aditya Dilipkumar Patil, Sargam Ramesh Singh   +1 more
doaj   +2 more sources

Pharmacoeconomic Analysis in Saudi Arabia: An Overdue Agenda Item for Action

Annals of Saudi Medicine, 2011
Pharmacoeconomics is a branch of health economics related to the most economical and efficient use of pharmaceuticals. Pharmacoeconomic research identifies, measures and compares the costs and outcomes (clinical, economic and humanistic) of ...
Al-Jazairi Abdulrazaq, Al-Qadheeb Nada, Ajlan Aziza   +2 more
doaj   +2 more sources

Pharmacoeconomic analysis of Cellex® in the treatment of ischemic stroke [PDF]

Качественная клиническая практика, 2018
Actuality. Acute cerebral circulation disordersremain an important problem of modern health care. Available evidence suggests that both reperfusion and neuroprotection are important to ensure a favorable outcome of treatment.
A. E. Cheberda, D. Yu. Belousov
doaj   +2 more sources

PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review

Рациональная фармакотерапия в кардиологии, 2015
The article reviews the pharmacoepidemiological and pharmacoeconomic trials of antihypertensive therapy, conducted during the last decades inRussia. Despite the increased interest to the issue of cost-effectiveness of arterial hypertension treatment in ...
T. S. Romanenko, A. V. Kontsevaya, S. V. Fitilev   +2 more
doaj   +4 more sources

Review of open libraries for pharmacoeconomic analysis in R environment [PDF]

Фармакоэкономика
Background. To reveal the full complexity of the relationship between medical intervention and disease outcome, new methods of analysis and modeling are actively being developed, and tools are becoming more complex, for the use of which it is important ...
I. A. Lackman, R. I. Sladkov, V. M. Timiryanova   +2 more
doaj   +2 more sources

PHARMACOECONOMIC ANALYSIS OF OLMESARTAN THERAPY IN THE INDIVIDUAL–LEVEL MANAGEMENT OF ARTERIAL HYPERTENSION

Российский кардиологический журнал, 2012
The pharmacoeconomic analysis compared the strategies of arterial hypertension (AH) management using different angiotensin II receptor blockers (ARB). The first stage of the analysis included the cost-effectiveness modelling in patients with moderate AH ...
S. G. Gorokhova, V. V. Ryazhenov
doaj   +1 more source

Pharmacoeconomic evaluation of drug supply for chemotherapy in small cell lung cancer [PDF]

, 2023
Evidence-based comprehensive pharmacoeconomic model for evaluation of drug supply for chemotherapy in small cell lung cancer improves registration of history cases and allows for pharmacoeconomic cost-effectiveness analysis considering features of each ...
Lunyova, Y. A.
core   +1 more source